We are live on ! Find out more
PCM

Perkins Capital Management Portfolio holdings

AUM $133M
1-Year Est. Return 127.86%
This Fund
S&P 500
This Quarter Est. Return
+23.37%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
AUM
$113M
AUM Growth
+$14M
Cap. Flow
-$1.47M
Cap. Flow %
-1.3%
Top 10 Hldgs %
43.47%
Holding
88
New
5
Increased
13
Reduced
43
Closed
5

Top Sells

Rank Stock Value
1
ONDS icon
Ondas Inc
ONDS
+$2.24M
2
XGN icon
Exagen
XGN
+$1.88M
3
VCEL icon
Vericel Corp
VCEL
+$497K
4
SERA icon
Sera Prognostics
SERA
+$363K
5
LLY icon
Eli Lilly
LLY
+$320K

Sector Composition

Rank Sector Weight
1 Healthcare 57.9%
2 Technology 26.28%
3 Communication Services 7.77%
4 Industrials 4.53%
5 Consumer Staples 2.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NXPI icon
51
NXP Semiconductors
NXPI
$58.6B
$524K 0.46%
2,300
VZ icon
52
Verizon
VZ
$191B
$519K 0.46%
11,808
COP icon
53
ConocoPhillips
COP
$141B
$497K 0.44%
5,250
GIS icon
54
General Mills
GIS
$19B
$442K 0.39%
8,775
-125
-1% -$6.27K
TGT icon
55
Target
TGT
$67B
$440K 0.39%
4,900
INTC icon
56
Intel
INTC
$517B
$438K 0.39%
13,050
-1,650
-11% -$40K
DYAI icon
57
Dyadic International
DYAI
$34.6M
$411K 0.36%
348,050
+300,200
+627% +$292K
BDSX icon
58
Biodesix
BDSX
$236M
$397K 0.35%
52,633
-353
-0.7% -$2.71K
CELC icon
59
Celcuity
CELC
$4.51B
$390K 0.34%
7,900
-3,800
-32% -$152K
VCEL icon
60
Vericel Corp
VCEL
$2.31B
$386K 0.34%
12,250
-13,850
-53% -$497K
BMY icon
61
Bristol-Myers Squibb
BMY
$130B
$380K 0.34%
8,430
-2,000
-19% -$93.4K
DGII icon
62
Digi International
DGII
$2.74B
$377K 0.33%
10,333
FAST icon
63
Fastenal
FAST
$57.4B
$368K 0.32%
7,500
DCI icon
64
Donaldson
DCI
$11.3B
$360K 0.32%
4,400
PLUS icon
65
ePlus
PLUS
$2.46B
$355K 0.31%
5,000
BLFS icon
66
BioLife Solutions
BLFS
$1.63B
$319K 0.28%
12,500
BP icon
67
BP
BP
$107B
$317K 0.28%
9,200
JNJ icon
68
Johnson & Johnson
JNJ
$623B
$297K 0.26%
1,600
COST icon
69
Costco
COST
$417B
$231K 0.2%
250
DGX icon
70
Quest Diagnostics
DGX
$26B
$229K 0.2%
1,200
XGN icon
71
Exagen
XGN
$156M
$221K 0.19%
20,075
-211,783
-91% -$1.88M
VELO
72
Velo3D Inc
VELO
$380M
$215K 0.19%
+70,000
New +$242K
ASUR icon
73
Asure Software
ASUR
$246M
$205K 0.18%
25,000
TCMD icon
74
Tactile Systems Technology
TCMD
$671M
$195K 0.17%
14,066
+2,866
+26% +$34.5K
APYX icon
75
Apyx Medical
APYX
$175M
$173K 0.15%
81,000
-146,000
-64% -$309K

Similar funds

Perkins Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Perkins Capital Management held 88 positions worth $113M, up 14% from $99.5M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Perkins Capital Management's Q3 2025 filing shows 5 new, 13 increased, 43 reduced and 5 closed positions. Its largest new stake was Lucid Diagnostics: 1,127,000 shares worth $1.14M. The largest sale was Ondas Inc, an estimated $2.24M.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 57% a quarter earlier, followed by Technology and Communication Services.

  • Perkins Capital Management's largest Q3 2025 buy was Lucid Diagnostics: 1,127,000 shares worth $1.14M.
  • Perkins Capital Management added most to Butterfly Network in Q3 2025, an estimated $1.07M increase.
  • Perkins Capital Management's biggest Q3 2025 reduction was Ondas Inc, cutting an estimated $2.24M.
  • Perkins Capital Management fully exited Sera Prognostics in Q3 2025, selling an estimated $363K.
  • Perkins Capital Management's ten largest holdings make up 43% of its $113M portfolio in Q3 2025.
  • Perkins Capital Management opened 5 new positions and closed 5 in Q3 2025.
  • Perkins Capital Management's portfolio value rose 14% quarter-over-quarter to $113M.

Based on Perkins Capital Management's 13F filing for Q3 2025, filed 31 Oct 2025.